Gaillet, Antoine
Azoulay, Elie
de Montmollin, Etienne
Garrouste-Orgeas, Maité
Cohen, Yves
Dupuis, Claire
Schwebel, Carole
Reignier, Jean
Siami, Shidasp
Argaud, Laurent
Adrie, Christophe
Mourvillier, Bruno
Ruckly, Stéphane
Forel, Jean-Marie
Timsit, Jean-Francois
Article History
Received: 29 July 2022
Accepted: 17 January 2023
First Online: 13 March 2023
Declarations
:
: The OutcomeRea™ database was declared to the “Comité consultatif français de l'informatique pour la recherche en santé” (CCTIRS) et la “Commission française de l'informatique et des libertés” (CNIL, #8999262), in accordance with French law, and this study was approved by the ethical committee of the French Society of Intensive Care (SRLF). Waiver for informed consent was granted because the study does not modify patients’ management and the data are anonymously collected.
: EA: Related to paper: none; Apart from the paper: fees for lectures from Gilead, Pfizer, Baxter and Alexion. His research group has been supported by Ablynx, Fisher & Payckle, Jazz Pharma, and MSD. CS: Related to paper: none; Apart from the paper: fees for speaking (Sanofi)—financial support for CME (Pfizer, MSD). JFT: Related to paper: none; Apart from the paper: advisory boards: Pfizer, Gilead, Merck, BD France, Shionogi. His research group has been supported by Merck, Thermofischer, Pfizer.